© Copyright 2020 Doctors Without Borders (MSF) Southern Africa | MSF-SA Association | Southern Africa Medical Unit
Mbongolwane & Eshowe HIV impact In population Survey
Despite a major increase in the South Africa’s antiretroviral treatment (ART) coverage and a reduction in mortality of AIDS-related causes since 2010, the overall national prevalence among 15-49 year olds is 21%. It reaches 27% in the province of KwaZulu Natal which is more than two-fold higher than the corresponding HIV prevalence rates in the Western Cape and the Northern Cape provinces.
BRIEF: Treatment scale-down ahead? Rationing the HIV response in the shadow of success
MSF’s briefing note “Treatment scale-down ahead? Rationing the HIV response in the shadow of success” outlines examples of gaps MSF teams observe in a subset of countries where we work (Malawi, Mozambique, Zimbabwe, Central African Republic and Guinea), where national HIV programs are facing critical challenges to sustain and scale up life-saving services amid the threat of declining international funding.
DR-TB Drugs Under The Microscope
Although tuberculosis (TB) is the number one infectious disease killer and one of the top ten causes of mortality worldwide, the global response to TB remains off track. The interim 2020 targets set by the World Health Organization (WHO) End TB Strategy – to reduce new TB infections by 20%, reduce TB deaths by 35%, and eliminate catastrophic costs of treatment for families – won’t be reached unless there is a dramatic increase in the pace of the global TB response
The UN High- Level Meeting on Tuberculosis
World leaders will meet in New York on 26 September 2018 for the first ever UN High-Level Meeting (HLM) on TB. Ahead of the summit, Doctors Without Borders (MSF) joins others in calling on governments to make firm commitments to close the deadly gaps in TB testing, treatment and prevention. To save lives, governments must pledge to scale up use of the tools we have to tackle TB today – and commit to developing and delivering faster, safer and simpler tools for tomorrow.